Steve Woodruff wrote 1 day ago: FDA to Watson on 24-week Trelstar: Ummm, not yet. Oh, and to Bayer and J&J for Xarelto: Ummmm, n … more →
Audrey Erbes wrote 6 days ago: Unfortunately, Roche is still Roche and not Genentech as Basel would have the general public believ … more →
Steve Woodruff wrote 6 days ago: Roche-Genentech – the cuts begin – Anxiety rippled through Genentech this week as the Sw … more →
sflawcn wrote 1 week ago: Following a ten year dispute between Shouthwest Pharma Co. and F. Hoffmann-La Roche AG, as well as b … more →
Jeremy G wrote 2 weeks ago: Some exciting deal news from the week: Neuromed, which licensed U.S. rights to its lead candidate E … more →
silico wrote 2 weeks ago: Cellular Dynamics and Roche have announced an expansion of their existing two year old agreement to … more →
Audrey Erbes wrote 2 weeks ago: Now come on…is Roche so naive to believe that industry folks will think Genentech is not Roche … more →
Chas Underwood III wrote 2 weeks ago: #25 - Valium Valium™ Price: $0.34 per pill Rich people have very difficult lives. They are con … more →
Steve Woodruff wrote 2 weeks ago: Ouch. Jury returns $ 1.67 billion verdict against Abbott (patent infringement vs J&J) – A … more →
jgoolsby wrote 2 weeks ago: Recruiting and interviewing for a Systems Engineer with experience working with Medical Devices. Roc … more →
Steve Woodruff wrote 2 weeks ago: I think it’s going to be more than 3 today…! Does Lantus (Sanofi drug for diabetes) incr … more →
silico wrote 3 weeks ago: Zurich-based Covagen and Roche have announced that they have entered a collaboration agreement under … more →
silico wrote 1 month ago: Halozyme Therapeutics has announced that Roche has selected a fifth exclusive target under the … more →
silico wrote 1 month ago: Bayhill Therapeutics has announced that it has entered into an exclusive worldwide license agreement … more →
silico wrote 1 month ago: Raptor Pharmaceuticals has signed a collaboration and licensing agreement with Roche to evaluate the … more →
silico wrote 1 month ago: Reuters is reporting that the venture arms of GlaxoSmithKline, Novartis, Roche and Eli Lilly are inv … more →
Steve Woodruff wrote 1 month ago: OK, so it’s a “baker’s three” (8) today. Makes up for yesterday’s zer … more →
Michael Becker wrote 1 month ago: In my prior article, I highlighted the “ASCO-effect,” which relates to the fact that biotechnology c … more →
qualitysmusic wrote 1 month ago: more about "Sébastien Tellier – Roche", posted with vodpod … more →